Neuroone Medical Technologies (NMTC) Inventory (2020 - 2026)

Neuroone Medical Technologies (NMTC) has reported Inventory for 7 consecutive years, with $2.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory rose 20.69% year-over-year to $2.3 million; the trailing twelve-month figure through Jun 2026 stood at $2.3 million (up 20.69% YoY), and the FY2025 full-year result was $2.2 million, down 15.5% from the prior year.
• Inventory grew to $2.3 million in Q2 2026 per NMTC's latest filing, from $2.1 million in the prior quarter.
• Across five years, Inventory topped out at $2.6 million in Q3 2024 and bottomed at $221903.0 in Q1 2022.
• Historically, Inventory has averaged $1.6 million across 5 years, with a median of $1.7 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Inventory soared 770.58% in 2022, then declined 15.5% in 2025.
• Over 5 years, Inventory stood at $903554.0 in 2022, then surged by 78.04% to $1.6 million in 2023, then increased by 20.03% to $1.9 million in 2024, then retreated by 13.71% to $1.7 million in 2025, then soared by 37.46% to $2.3 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $2.3 million, $2.1 million, and $1.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.